Envoy Medical (COCH)
NASDAQ:COCH
Total Valuation
Envoy Medical has a market cap or net worth of $51.13M. The enterprise value is $11.84M.
Market Cap$51.13M
Enterprise Value$11.84M
Share Statistics
Envoy Medical has 76,881,110 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding76,881,110
Owned by Insiders40.46%
Owned by Institutions0.10%
Financial Efficiency
Envoy Medical’s return on equity (ROE) is 2.02 and return on invested capital (ROIC) is 786.93%.
Return on Equity (ROE)2.02
Return on Assets (ROA)-2.78
Return on Invested Capital (ROIC)786.93%
Return on Capital Employed (ROCE)7.41
Revenue Per Employee5.74K
Profits Per Employee-565.62K
Employee Count42
Asset Turnover0.03
Inventory Turnover0.57
Valuation Ratios
The current PE Ratio of Envoy Medical is ―. Envoy Medical’s PEG ratio is 0.03.
PE Ratio―
PS Ratio53.77
PB Ratio-1.10
Price to Fair Value-1.10
Price to FCF-0.70
Price to Operating Cash Flow-0.76
PEG Ratio0.03
Income Statement
In the last 12 months, Envoy Medical had revenue of 241.00K and earned -23.76M in profits. Earnings per share was -1.23.
Revenue241.00K
Gross Profit-633.00K
Operating Income-22.27M
Pretax Income-23.76M
Net Income-23.76M
EBITDA-21.97M
Earnings Per Share (EPS)-1.23
Cash Flow
In the last 12 months, operating cash flow was -18.20M and capital expenditures -179.00K, giving a free cash flow of -18.38M billion.
Operating Cash Flow-18.20M
Free Cash Flow-18.38M
Free Cash Flow per Share-0.24
Dividends & Yields
Envoy Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta>-0.01
52-Week Price Change-51.46%
50-Day Moving Average0.68
200-Day Moving Average0.97
Relative Strength Index (RSI)44.08
Average Volume (3m)394.38K
Important Dates
Envoy Medical upcoming earnings date is May 20, 2026, Before Open (Confirmed).
Last Earnings DateMar 23, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
Envoy Medical as a current ratio of 0.54, with Debt / Equity ratio of -7.81%
Current Ratio0.54
Quick Ratio0.41
Debt to Market Cap0.07
Net Debt to EBITDA0.13
Interest Coverage Ratio-14.01
Taxes
In the past 12 months, Envoy Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Envoy Medical EV to EBITDA ratio is -0.46, with an EV/FCF ratio of -0.55.
EV to Sales42.06
EV to EBITDA-0.46
EV to Free Cash Flow-0.55
EV to Operating Cash Flow-0.56
Balance Sheet
Envoy Medical has $3.74M in cash and marketable securities with $919.00K in debt, giving a net cash position of $2.82M billion.
Cash & Marketable Securities$3.74M
Total Debt$919.00K
Net Cash$2.82M
Net Cash Per Share$0.04
Tangible Book Value Per Share-$0.60
Margins
Gross margin is -262.66%, with operating margin of -9240.66%, and net profit margin of -9857.26%.
Gross Margin-262.66%
Operating Margin-9240.66%
Pretax Margin-9857.26%
Net Profit Margin-9857.26%
EBITDA Margin-9115.35%
EBIT Margin-9240.66%
Analyst Forecast
The average price target for Envoy Medical is $2.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.50
Price Target Upside262.32% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-25.18%
EPS Growth Forecast-9.71%